Acute Myeloid Leukemia (AML) is a form of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells. Among its subtypes, AML-M2 stands out due to a specific chromosomal translocation known as AML1-ETO. This translocation plays a significant role in the diagnosis and treatment of AML-M2. Understanding the symptoms of AML1-ETO AML-M2 is crucial for early detection and effective management of the condition. DNA Labs UAE offers a specialized test for this subtype of AML, priced at 1050 AED. For more information, please visit our website.
Symptoms of AML1-ETO AML-M2
The symptoms of AML1-ETO AML-M2 are similar to those of other types of leukemia, but recognizing them early can lead to a timely diagnosis and better outcomes. Common symptoms include:
- Fatigue and weakness, which are due to anemia caused by a shortage of red blood cells.
- Fever and infections, as the abnormal white blood cells cannot fight off infections effectively.
- Easy bruising or bleeding, resulting from a reduced number of platelets in the blood.
- Bone or joint pain, which occurs when the leukemia cells spread to these areas.
- Weight loss and loss of appetite, which are more general symptoms but can be associated with AML-M2.
- Swollen lymph nodes, liver, or spleen, caused by the accumulation of leukemia cells in these organs.
It’s important to note that these symptoms can also be associated with other, less severe conditions. However, if you or someone you know is experiencing a combination of these symptoms, it’s important to consult a healthcare provider for further evaluation.
AML1ETO AML-M2 Test at DNA Labs UAE
DNA Labs UAE provides a specialized test for detecting the AML1-ETO translocation characteristic of AML-M2. The test cost is set at 1050 AED. This genetic test is a powerful tool for diagnosing AML-M2, guiding treatment decisions, and monitoring response to treatment. The test involves a simple blood sample from which DNA is extracted and analyzed for the presence of the AML1-ETO translocation.
Importance of Early Detection
Early detection of AML1-ETO AML-M2 is critical for effective treatment. The presence of the AML1-ETO translocation can influence the choice of chemotherapy drugs and the need for a bone marrow transplant. Additionally, monitoring the levels of the AML1-ETO transcript during and after treatment can help assess the effectiveness of the treatment and detect any signs of relapse early.
Conclusion
AML1-ETO AML-M2 is a subtype of acute myeloid leukemia that requires specialized testing for accurate diagnosis and treatment planning. Recognizing the symptoms early and undergoing the AML1ETO AML-M2 test at DNA Labs UAE can significantly improve the chances of successful treatment. With the test priced at 1050 AED, it’s an accessible option for those in need of this crucial diagnostic tool. For more information and to schedule a test, please visit DNA Labs UAE.
